Barry Hock
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 24, 2023
Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.Paula E Keating, Barry D Hock, Stewart M Smith
|Sep 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab.Barry D Hock, Liping Goddard, Sean A MacPherson
|Jun 20, 2020
Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies.Barry D Hock, Judith L McKenzie, Matthew Strother
|Nov 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre.Barry D Hock, Katie S Mulholland, Peter Ganly
|Aug 10, 2018
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.Murray L Barclay, Shwan Karim, Esther T Johanna Helms
Pageof 1
